Corticosteroids for the resolution of malignant bowel obstruction in advanced gynaecological and gastrointestinal cancer

Cochrane Database of Systematic Reviews

Volumn 2017, Issue 6, 2000, Pages

  Feuer, David J ^a   Broadley, Karen E ^b  

^a BARTS HEALTH NHS TRUST   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; PLACEBO; GLUCOCORTICOID;

ADVANCED CANCER; CANCER SURVIVAL; CONSTIPATION; DIGESTIVE SYSTEM CANCER; DRUG EFFICACY; DRUG INDICATION; FEMALE GENITAL TRACT CANCER; HOSPITALIZATION; HUMAN; INTESTINE OBSTRUCTION; MORTALITY RATE; NAUSEA; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; VOMITING; FEMALE; FEMALE GENITAL TRACT TUMOR; GASTROINTESTINAL TUMOR; MALE; PALLIATIVE THERAPY;

FEMALE; GASTROINTESTINAL NEOPLASMS; GENITAL NEOPLASMS, FEMALE; GLUCOCORTICOIDS; HUMANS; INTESTINAL OBSTRUCTION; MALE; PALLIATIVE CARE;

EID: 84921430454     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD001219     Document Type: Review

References (44)

1. Baines, M . To assess the most effective symptom management in bowel obstruction. Personal communication 1997. 3368908
2. Bruera E, Seifert L, Watanabe S, Babul N, Dauke A, Harsanyi Z, et al. Chronic nausea in advanced cancer patients: a retrospective assessment of a metoclopramide-based antiemetic regimen. Journal of Pain and Symptom Management 1996;11:147-53. 3368910
3. Fainsinger RL, Spachynski K, Hanson J, Bruera E. Symptom control in terminally ill patients with malignant bowel obstruction (MBO). Journal of Pain and Symptom Management 1994;9:12-8. 3368912
4. Farr WC. The use of corticosteroids for symptom management in terminally ill patients. American Journal of Hospice Care 1990;1:41-6. 3368914
5. Hardy JR, Ling PJ, Mansi J, Isaacs R, Bliss J, A'Hern R, et al. Pitfalls in placebo controlled trials in palliative care: dexamethasone for the palliation of malignant bowel obstruction. Palliative Medicine 1998;12:437-43. 3368916
6. Hardy JR, Ling PJ, Mansi J, Isaacs R, Bliss J, A'Hern R, et al. Pitfalls in placebo controlled trials in palliative care: dexamethasone for the palliation of malignant bowel obstruction. Palliative Medicine 1998;12:437-43. 3368918
7. Laval G, Girardier J, Lassauniere JM, Schaerer . Multi-centre double-blind randomised clinical trial on the use of methylprednisolone in non-surgical cancer related bowel obstruction. Personal communication 1998. 3368920
8. Luczak J, Czarnecka-Porzucek I. Clinical experiences in the treatment of malignant bowel obstruction in Poland. Abstracts of the 4th Congress of European Association for Palliative Care. 1995:114-5. 3368922
9. Philip J, Do T, Lickiss N, Grant P, Hacker N. Corticosteroids in gastrointestinal obstruction in patients with gynaecological cancer (abstract). International Journal of Gynecological Cancer International Journal of Gynecological Cancer 1997;7(Supp 2):87. 3368924
10. Thorsen AB, Yung NS, Leung AC. Administration of drugs by infusion pumps in palliative medicine. Annals Academy of Medicine Singapore 1994;23:209-11. 3368926
11. Ashino Y, Muto A, Kanno A, Ito H, Moriyama A, Hiraga M. [How to palliate the symptoms of terminally ill patients at home]. Gan To Kagaku Ryoho/Cancer and Chemotherapy 1996;23(Suppl 3):297-303. 3368928
12. Clarke IM. A dynamic ileus and amitriptyline. BMJ 1971;2:531. 3368930
13. Costa I, Goncalves F. Intestinal obstruction in cancer patients - palliative care. Acta Medica Portugesa 1997;10:381-5. 3368932
14. Fainsinger RL. Integrating medical and surgical treatments in gastrointestinal, genitourinary, and biliary obstruction in patients with cancer. Hematology/Oncology Clinics of North America 1996;10:173-88. 3368934
15. Fernando ON, Moorhead J. Absorption of enteric-coated prednisolone [letter]. BMJ 1979;1:1975. 3368936
16. Reid DB. Palliative management of bowel obstruction. The Medical Journal of Australia 1988;148:54. 3368938
17. Steiner N. Controlling the symptoms in palliative care: when it's terminal [Contrôle des symptomes en soins palliatifs: l'ileus terminal]. Med et Hyg 1991;49:1182-92. 3368940
18. Twycross R. Alimentary symptoms. In: Twycross R editor(s). Symptom Management in Advanced Cancer. Oxford: Radcliffe Medical Press, 1997:158-221. 3368942
19. Walsh TD, West TS. Controlling symptoms in advanced cancer. BMJ 1988;296:477-81. 3368944
20. Baena CJ, Pastorin J, Rueda A, Senra A. [Octreotide in relieving symptoms due to bowel obstruction of advanced cancer patients [2]]. Oncologia (Spain) 1996;19:76-7. 3368946
21. Chang-Walter YM, Burnett WE. Complete colonic obstruction due to adenocarcinoma. Dissertation Abstracts International 1977; Vol. S1977. 3368948
22. Dragstedt CA. Studies in intestinal obstruction. Dissertation Abstracts International 1926; Vol. S0330. 3368950
23. Laval G, Girardier J, Lassauniere HM, Leduc B, Haond C, Schaerer R. The use of steroids in the management of inoperable intestinal obstruction in terminal cancer patients: do they remove the obstruction?. Palliative Medicine 2000;14:3-10. 3368952
24. Steiner NE. Palliative therapeutic approaches of the obstruction intestinal in the cancer patients at the end of the lifetime [Approches therapeutiques palliatives de l'obstruction intestinales chez les patients cancereux en fin de vie]. Dissertation Abstracts International 1986; Vol. 55 03C. 3368954
25. Allan GS. Nausea and vomiting. In: Doyle D, Hanks GWC, MacDonald N editor(s). Oxford Textbook of Palliative Medicine. Oxford: Oxford University Press, 1993:282-90.
26. Baines M, Oliver DJ, Carter RL. Medical management of intestinal obstruction in patients with advanced malignant disease. Lancet 1985;2:990-3.
27. Baines M. The pathophysiology and management of malignant intestinal obstruction. In: Doyle D, Hanks GWC, MacDonald N editor(s). Oxford Textbook of Palliative Medicine. Oxford: Oxford University Press, 1998:526-34.
28. Butler JA, Cameron BL, Morrow M, Kahng K, Tom J. Small bowel obstruction in patients with a prior history of cancer. American Journal of Surgery 1991;162:624.
29. Chalmers TC, Levin H, Sacks HS, Reitman D, Berrier J, Nagalingam R. Meta-analysis of clinical trials as a a scientific discipline. I: control of bias and comparison with large co-operative. Statistics in Medicine 1987;6:315-25.
30. CRC . Facts on Cancer. Factsheets 1-26. London: Cancer Research Campaign, 1995.
31. Dvoretsky PM, Richards KA, Angel C, Rabinowitz L, Beecham JB, Bonfiglio TA. Survival time, causes of death and tumor/treatment-related morbidity in 100 women with ovarian cancer. Human Pathology 1988;19:1273-9.
32. Dvoretsky PM, Richards KA, Angel C, Rabinowitz L, Stoler MH, Beecham JB, et al. Distribution of disease at autopsy in 100 women with ovarian cancer. Human Pathology 1988;19:57-63.
33. Ellershaw JE, Kelly MJ. Corticosteroids and peptic ulceration. Palliative Medicine 1994;8:313-9.
34. Fainsinger RL, Spachynski K, Hanson J, Bruera E. Symptom control in terminally ill patients with malignant bowel obstruction. Journal of Pain and Symptom Management 1994;9(1):12-8.
35. Hardy J, Rees E, Ling J, Burman R, Feuer D, Broadley K. A survey of dexamethasone use in a palliative care unit (Abstract). Vth Congress of the European Association for Palliative Care. 1997; Vol. S21.
36. Jadad AR, Moore A, Carroll D, Jenkinson C, Reyolds DJM, Gavaghan D, et al. Assessing the quality of reports of randomised clinical trials: is blinding necessary?. Controlled Clinical Trials 1996;17:1-12.
37. Mann T. Clinical Guidelines: using clinical guidelines to improve patient care within the NHS. Leeds: NHS Executive, 1996.
38. Osteen RT, Guyton S, Steel G Jr, Wilson RE. Malignant intestinal obstruction. Surgery 1980;87:611-5.
39. Ozols RF, Schwartz PE, Eifel PJ. Ovarian cancer, fallopian tube carcinoma and peritoneal cancer. In: DeVita VT, Hellman S, Rosenberg SA editor(s). Cancer. Principles and Practice of Oncology. Philadelphia/New York: Lippincott - Raven, 1997:1502-39.
40. Ripamonti C, De Conno F, Ventafridda V, Rossi B, Baines MJ. Management of bowel obstruction in advanced and terminal cancer patients. Ann Oncol 1993;4:15-21.
41. Ripamonti C. Malignant bowel obstruction in advanced and terminal cancer patients. Eur J Pall Care 1994;1(1):16-9.
42. Rose PG, Piver S, Tsukada Y, Lau T. Metastatic patterns in histologic variants of ovarian cancer. An autopsy study. Cancer 1978;64:1508-13.
43. Twycross R. Corticosteroids. In: Twycross R editor(s). Pain Relief in Advanced Cancer. Churchill Livingston, 1994:425-53.
44. Feuer D, Broadley KE. Systematic review and meta-analysis of corticosteroids for the resolution of malignant bowel obstruction in advanced gynaecological and gastrointestinal cancer. Annals of Oncology 1999;10(9):1035-41. [MEDLINE: AN: 20038895]